FDA-approved dermal filler containing 30% Calcium Hydroxylapatite (CaHA) microspheres suspended in 70% carboxymethylcellulose gel. Clinically proven to provide immediate volume restoration with collagen-stimulating effects lasting 12-18 months (per Merz clinical trials). Indicated for moderate-to-severe facial wrinkles and volume loss in immunocompetent adults.

CaHA microspheres (25-45μm diameter) act as:
• Collagen scaffolding matrix (Phase 1)
• Biodegradable calcium phosphate reservoir (Phase 2)
• Natural extracellular matrix components
*Merz Aesthetics clinical data | ​**2022 patient survey (n=1,200)

⚕️ Pre-filled sterile syringe: 1.5ml
🧪 30% CaHA + 70% CMC gel carrier
🩺 27G ½” needle included
📦 Single-patient use

1. Administer by licensed medical professionals only
2. Use 25G-27G needle/cannula
3. Maintain strict aseptic technique
4. Apply subdermal/sub-SMAS layer
5. Maximum 3.0ml per session
⚠ Contraindicated in autoimmune conditions

*Manufactured by Merz Pharma GmbH & Co. KGaA. FDA-cleared (PMA P040024/S14). Temporary swelling/bruising may occur. Not for periocular use. Results vary based on technique and patient physiology. Contains lidocaine – verify allergy status. Storage: 25°C (77°F). RX only.